Danaher The Quiet Achiever With COVID-19 Vaccines and Therapeutics

Danaher is a name not often linked to the Coronavirus vaccine industry. In fact DHR has been entrenched in the development of COVID-19 vaccines and therapeutics through its $21.4 bln acquisition of Cytiva last March and raised its Q1 guidance to the high end. 

Tilray European Weed Buy Sees Revenue Increase Five Fold But Still Reports Big Losses

Canadian marijuana producer Tilray reported mixed third-quarter earnings after the close Tuesday. Revenue beat expectations but losses were larger than expected with higher costs and lower average selling prices. $TLRY rose over 2% on the report.

California Loves Their Weed – $3.1 Billion Legal Sales By 2019

California is considered the world’s largest marijuana market and it’s legal cannabis market is currently on track to grow 23% in 2019 to $3.1 billion and to reach $7.2 billion in 2024, a 19% compound annual growth rate (CAGR) over the next five years.

Tilray Reports Another Big Loss With Marijuana Selling Price Down A Third

Canadian marijuana producer Tilray reported mixed second-quarterearnings aftet the close Tuesday. Revenue beat expectations but losses were larger than expected with huigher costs and lower average selling prices. $TLRY slid over 5% on the report.

Soliton Cellulite, Fat and Tattoo Removal Technology Spikes Price Volatilty

Soliton stock volatilty has soared with daily 25% and 10% moves up and down since news on $SOLY’s proprietary Rapid Acoustic Pulse (RAP) device that uses acoustic shockwaves to dramatically accelerate the removal of tattoos, reduce cellulite and enhance existing fat removal technologies.

Sangamo and Pfizer Focus on Translating Genomic Medicines Using Gene Therapy

Sangamo and Pfizer announced their focus on translating genomic medicines using gene therapy for severe hemophilia A has shown promising results. Shares in $SGMO and $PFE reacted positively to the news.

T2 Biosystems Highlights Whole Blood innovations at Infectious Diseases Conference

Emerging leader in the development of innovative medical diagnostic products TT2 Biosystems will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panelspositively impact patients with bloodstream infections at Infectious Diseases Conference.

Melinta Therapeutics Presents at Clinical Microbiology & Infectious Diseases Congress

Melinta Therapeutics $MLNT focusing on the development and commercialization of novel antibiotics to treat serious bacterial infections presented multiple presentations at the European Congress of Clinical Microbiology Infectious Diseases (ECCMID).

U.S. The World’s Largest Medical Device Market and Export Leader

The medical device market in the U.S is the largest in the world with a market size of near $156 billion that is around 40 percent of the medical technology market with U.S. exports over $41 billion in 2017 the Department of Commerce shows.